Rocket Lab Corporation (NASDAQ:RKLB) advanced 7% on Wednesday after completing an at-the-market equity offering program, according to the company’s disclosures.
The space launch and systems firm sold 6,726,862 shares through at-the-market transactions, producing aggregate gross proceeds of approximately $474 million before commissions and expenses. In addition to those sales, Rocket Lab entered into collared forward transactions that involve 7,451,200 shares with minimum expected proceeds of approximately $474 million and maximum expected proceeds of approximately $642 million.
The ATM program followed a prospectus supplement filed by the company on March 17, 2026, under which Rocket Lab could offer and sell shares with an aggregate offering price of up to $1 billion. The company noted that the collared forward transactions are tied to maturity dates scheduled for April 2028, though the actual amount realized under those transactions will depend on whether Rocket Lab elects to settle before maturity and on the cap and floor prices established in each contract.
Rocket Lab said it plans to apply net proceeds to fund future growth initiatives, which may include potential acquisitions, as well as for general corporate and working capital purposes. The firm described the fundraising as part of its broader capital plan to support operational objectives.
The stock’s gain on Wednesday occurred amid broader strength in equity markets, a factor the company did not quantify but which coincided with the announcement and completion of the transactions.
Transaction highlights
- 6,726,862 shares sold in at-the-market transactions for roughly $474 million gross.
- Collared forward transactions cover 7,451,200 shares with expected proceeds between about $474 million and $642 million.
- Offering program authorized by a March 17, 2026 prospectus supplement for up to $1 billion in aggregate offering price.
The company’s statements make clear that the gross proceeds cited are before commissions and expenses, and that the final outcomes of the collared forwards hinge on settlement timing and the pre-set cap and floor prices. Rocket Lab did not provide further detail in its announcement about expected timing for any use of proceeds or specific acquisition targets.
Investors considering the company’s equity should note the transactional details and the conditional nature of the collared forward receipts as described by the company. The financing activity closes a chapter of capital raising under the ATM program while leaving flexibility tied to forward contract settlement options.